Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FSME-IMMUN 0.5ml Seropersistence and Second Booster in Adults
NCT00503529Phase 4Completed
- Sponsor
- Pfizer
- Start
- Jul 2007
- Primary completion
- Jul 2010
- Countries
- 1
01
Overview
A Phase 4 trial of FSME-IMMUN in tick-borne encephalitis (TBE), sponsored by Pfizer. Started Jul 2007; status: completed.
02
Drugs
FSME-IMMUN
03
Conditions
tick-borne encephalitis (TBE)
Beyond the preview
Go deeper on NCT00503529.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00503529.